Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Cebranopadol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 247,298Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 863513-91-1, Grt6005, Grt-6005, Grt 6005, 863513-93-3, 7gdw9s3gn3
    Molecular Formula
    C24H27FN2O
    Molecular Weight
    378.5  g/mol
    InChI Key
    CSMVOZKEWSOFER-UHFFFAOYSA-N
    FDA UNII
    7GDW9S3GN3
    Cebranopadol is an orally available benzenoid that acts as an opioid peptide receptor agonist for the nociceptin/orphanin FQ peptide receptor (opioid receptor like -1; OPRL1; ORL-1; NOP; kappa-type 3 opioid receptor) and the classical opioid receptors, mu, delta and kappa, with potential anti-nociceptive activity. Upon oral administration, cebranopadol binds to NOP and the mu, delta and kappa opioid receptors, which enhances NOP- and opioid receptor-mediated signaling, interferes with the sensation of pain and results in an analgesic effect. NOP, a member of the opioid receptor family, and its endogenous ligand nociceptin play key roles in the regulation of various brain activities including pain, and some inflammatory and immune responses.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    6-fluoro-N,N-dimethyl-1'-phenylspiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine
    2.1.2 InChI
    InChI=1S/C24H27FN2O/c1-27(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(25)8-9-21(20)26-22/h3-9,16,26H,10-15H2,1-2H3
    2.1.3 InChI Key
    CSMVOZKEWSOFER-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5
    2.2 Other Identifiers
    2.2.1 UNII
    7GDW9S3GN3
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 6'-fluoro-4',9'-dihydro-n,n-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'h)-pyrano(3,4-b)indol)-4-amine

    2.3.2 Depositor-Supplied Synonyms

    1. 863513-91-1

    2. Grt6005

    3. Grt-6005

    4. Grt 6005

    5. 863513-93-3

    6. 7gdw9s3gn3

    7. Cebranopadol ((1alpha,4alpha)stereoisomer)

    8. 863513-91-1 (free Base)

    9. (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine

    10. 6-fluoro-n,n-dimethyl-1'-phenylspiro[4,9-dihydro-3h-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine

    11. Spiro(cyclohexane-1,1'(3'h)-pyrano(3,4-b)indol)-4-amine, 6'-fluoro-4',9'-dihydro-n,n-dimethyl-4-phenyl-, Trans-

    12. Trans-6'-fluoro-n,n-dimethyl-4-phenyl-4',9''-dihydro-3'h-spiro(cyclohexane-1,1'-pyrano(3,4-b)indol)-4-amine

    13. 6-fluoro-n,n-dimethyl-1'-phenyl-spiro[4,9-dihydro-3h-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine

    14. Cebranopadol [inn]

    15. Cebranopadol [usan:inn]

    16. Unii-7gdw9s3gn3

    17. Cebranopadol (usan/inn)

    18. Cebranopadol [usan]

    19. Cebranopadol(grt-6005)

    20. Schembl154336

    21. Schembl566256

    22. Gtpl8866

    23. Chembl2364605

    24. Chembl3545616

    25. Chembl3962932

    26. Schembl10035739

    27. Schembl14183935

    28. Schembl19336241

    29. Bdbm177926

    30. Dtxsid001031965

    31. Bcp09612

    32. Ex-a1095

    33. Zinc3950145

    34. Bdbm50101095

    35. Bdbm50101112

    36. Bdbm50533342

    37. Akos025290738

    38. Cs-1323

    39. Db12830

    40. Sb16531

    41. Ncgc00378895-01

    42. Ncgc00378895-02

    43. Ac-36077

    44. As-35183

    45. Hy-15536

    46. Ft-0774945

    47. D10436

    48. Us9120797, 24

    49. Us9120797, 25

    50. Q19596315

    51. (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4-b]indole]-4-amine

    2.4 Create Date
    2006-11-06
    3 Chemical and Physical Properties
    Molecular Weight 378.5 g/mol
    Molecular Formula C24H27FN2O
    XLogP34.3
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count2
    Exact Mass378.21074165 g/mol
    Monoisotopic Mass378.21074165 g/mol
    Topological Polar Surface Area28.3 Ų
    Heavy Atom Count28
    Formal Charge0
    Complexity553
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of chronic pain